Clinicopathological Predictors of High Mitotic Rate in Gastrointestinal Stromal Tumors: A Cross-Sectional Study in Iraq

Abood, R. A., Alasady, O. G., & Khalaf, A. A. (2018). Gastrointestinal stromal tumors in Southern Iraq: clinico-pathologic patterns and risk stratification. Asian Journal of Biomedical and Pharmaceutical Sciences, 7(2), 432–440. https://doi.org/http://dx.doi.org/10.18081/2333-5106/018-7/432-440

Alfagih, A., AlJassim, A., Alshamsan, B., Alqahtani, N., & Asmis, T. (2022). Gastrointestinal Stromal Tumors: 10-Year Experience in Cancer Center—The Ottawa Hospital (TOH). Current Oncology, 29(10), 7148–7157. https://doi.org/10.3390/curroncol29100562

Alshok, M. M. (2020). A clinical study on GIST in Babylon. Oncology and Radiotherapy, 14(3), 1–5.

Casali, P. G., Blay, J.-Y., Abecassis, N., Bajpai, J., & Bauer, S. (2022). Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 33(1), 20–33. https://doi.org/10.1016/j.annonc.2021.09.005

Casali, P. G., & Le Cesne, A. (2021). Gastrointestinal stromal tumors: New horizons. Nature Reviews Clinical Oncology, 18, 621–633.

Casali, P. G., Le Cesne, A., Poveda Velasco, A., Kotasek, D., Rutkowski, P., Hohenberger, P., Fumagalli, E., Judson, I. R., Italiano, A., Gelderblom, H., Adenis, A., Hartmann, J. T., Duffaud, F., Goldstein, D., Broto, J. M., Gronchi, A., Dei Tos, A. P., Marréaud, S., van der Graaf, W. T. A., … Blay, J.-Y. (2015). Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial. Journal of Clinical Oncology, 33(36), 4276–4283. https://doi.org/10.1200/JCO.2015.62.4304

DeMatteo, R. P., Gold, J. S., Saran, L., Gönen, M., Liau, K. H., Maki, R. G., Singer, S., Besmer, P., Brennan, M. F., & Antonescu, C. R. (2008). Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer, 112(3), 608–615. https://doi.org/10.1002/cncr.23199

Espinosa, I., Lee, C.-H., Kim, M. K., Rouse, B.-T., Subramanian, S., Montgomery, K., Varma, S., Corless, C. L., Heinrich, M. C., Smith, K. S., Wang, Z., Rubin, B., Nielsen, T. O., Seitz, R. S., Ross, D. T., West, R. B., Cleary, M. L., & van de Rijn, M. (2008). A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. American Journal of Surgical Pathology, 32(2), 210–218. https://doi.org/10.1097/PAS.0b013e3181238cec

Fletcher, C. D. M., Berman, J. J., Corless, C., Gorstein, F., Lasota, J., Longley, B. J., Miettinen, M., O’Leary, T. J., Remotti, H., Rubin, B. P., Shmookler, B., Sobin, L. H., & Weiss, S. W. (2002). Diagnosis of gastrointestinal stromal tumors: A consensus approach. Human Pathology, 33(5), 459–465. https://doi.org/10.1053/hupa.2002.123545

Haller, F., Cortis, J., Helfrich, J., Cameron, S., Schüler, P., Schwager, S., Gunawan, B., Füzesi, L., & Agaimy, A. (2011). Epithelioid/mixed phenotype in gastrointestinal stromal tumors with KIT mutation from the stomach is associated with accelerated passage of late phases of the cell cycle and shorter disease-free survival. Modern Pathology, 24(2), 248–255. https://doi.org/10.1038/modpathol.2010.188

IJzerman, N. S., Drabbe, C., den Hollander, D., Mohammadi, M., van Boven, H., Desar, I. M. E., Gelderblom, H., Grünhagen, D. J., Reyners, A. K. L., van Noesel, M. M., Mathijssen, R. H. J., Steeghs, N., & van der Graaf, W. T. A. (2020). Gastrointestinal Stromal Tumours (GIST) in Young Adult (18–40 Years) Patients: A Report from the Dutch GIST Registry. Cancers (Basel), 12(3), 730. https://doi.org/10.3390/cancers12030730

Joensuu, H. (2008). Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Human Pathology, 39(10), 1411–1419. https://doi.org/10.1016/j.humpath.2008.06.025

Kelly, C. M., Gutierrez Sainz, L., & Chi, P. (2021). The management of metastatic GIST: current standard and investigational therapeutics. Journal of Hematology & Oncology, 14(1), 2. https://doi.org/10.1186/s13045-020-01026-6

Kramer, K., Knippschild, U., Mayer, B., Bögelspacher, K., Spatz, H., Henne-Bruns, D., Agaimy, A., Schwab, M., & Schmieder, M. (2015). Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST). BMC Cancer, 15, 57. https://doi.org/10.1186/s12885-015-1054-y

Mazzola, P. (2021). Epidemiology and treatment of GIST: an update. Cancers (Basel), 13, 6072.

Miettinen, M., & Lasota, J. (2006). Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Archives of Pathology & Laboratory Medicine, 130(10), 1466–1478. https://doi.org/10.5858/2006-130-1466-GSTROM

Nishida, T., Blay, J.-Y., Hirota, S., Kitagawa, Y., & Kang, Y.-K. (2016). The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer, 19(1), 3–14. https://doi.org/10.1007/s10120-015-0526-8

Parab, T. M., DeRogatis, M. J., Boaz, A. M., Grasso, S. A., Issack, P. S., Duarte, D. A., Urayeneza, O., Vahdat, S., Qiao, J.-H., & Hinika, G. S. (2019). Gastrointestinal stromal tumors: a comprehensive review. Journal of Gastrointestinal Oncology, 10(1), 144–154. https://doi.org/10.21037/jgo.2018.08.20

Shi, Y.-N., Li, Y., Wang, L.-P., Wang, Z.-H., Liang, X.-B., & Liang, H. (2017). Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China. Medicine (Baltimore), 96(46), e8240. https://doi.org/10.1097/MD.0000000000008240

Søreide, K., Sandvik, O. M., Søreide, J. A., Giljaca, V., Jureckova, A., & Bulusu, V. R. (2016). Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiology, 40, 39–46. https://doi.org/10.1016/j.canep.2015.10.031

Supsamutchai, C., Wilasrusmee, C., Hiranyatheb, P., Jirasiritham, J., Rakchob, T., & Choikrua, P. (2018). A cohort study of prognostic factors associated with recurrence or metastasis of gastrointestinal stromal tumor (GIST) of stomach. Annals of Medicine and Surgery, 35, 1–5. https://doi.org/10.1016/j.amsu.2018.08.010

von Mehren, M., & Joensuu, H. (2018). Gastrointestinal Stromal Tumors. Journal of Clinical Oncology, 36(2), 136–143. https://doi.org/10.1200/JCO.2017.74.9705

von Mehren, M., Kane, J. M., Agulnik, M., Bui, M. M., Carr-Ascher, J., Choy, E., Connelly, M., Dry, S., Ganjoo, K. N., & Gonzalez, R. J. (2022). Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 20(7), 815–833. https://doi.org/10.6004/jnccn.2022.0035

Wu, C.-E., Tzen, C.-Y., Wang, S.-Y., & Yeh, C.-N. (2019). Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View. Cancers (Basel), 11(5), 679. https://doi.org/10.3390/cancers11050679

Yang, D. Y., Wang, X., Yuan, W. J., & Chen, Z. H. (2019). Metastatic pattern and prognosis of gastrointestinal stromal tumor (GIST): a SEER-based analysis. Clinical and Translational Oncology, 21(12), 1654–1662. https://doi.org/10.1007/s12094-019-02094-y